Simon Read, Chief Scientific Officer at Ra Pharmaceuticals, Inc. (RARX), sold 10,000 shares at $47.08 ($471K) on 2019-12-17, disclosed to the SEC on 2019-12-18.
Open-market sale of $471k RARX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RARX | SELL | 2019-11-18 | $467K | — | Filing → |
| RARX | SELL | 2019-10-17 | $469K | — | Filing → |
| RARX | SELL | 2019-09-16 | $254K | — | Filing → |